Anebulo stockholders approve increase in authorized shares and re-elect directors

Anebulo Pharmaceuticals, Inc.

Stockholders re-elected Jason M. Aryeh and Bimal Shah as Class III directors with ~23.1M votes for each.
Ratified EisnerAmper LLP as independent auditor for fiscal 2024 (23,302,065 for, 2,075 against).
Approved amendment to increase authorized common shares from 40M to 50M (23,263,127 for).
The authorized share amendment was filed with Delaware Secretary of State on Nov 20, 2023.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Anebulo Pharmaceuticals, Inc. shareholders approved Approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 50,000,000. at the 2023-11-20 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-11-20

Exact text from the filing

Proposal No. 3 – Approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 50,000,000.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Anebulo Pharmaceuticals, Inc. shareholders approved Ratification of the selection by the Audit Committee of the Board of Directors of EisnerAmper LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2024. at the 2023-11-20 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-11-20

Exact text from the filing

Proposal No. 2 – Ratification of the selection by the Audit Committee of the Board of Directors of EisnerAmper LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2024.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Anebulo Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2023-11-20 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-11-20

Exact text from the filing

Proposal No. 1 - Election of Directors The stockholders elected the following two individuals to the Board of Directors to hold office until the 2026 Annual Meeting of Stockholders as Class III directors.

View on SEC.gov

Browse all shareholder votes →

Anebulo Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-042292

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.